Day

August 24, 2026
Meblanios is an injectable Aztreonam and Avibactam combination relevant to the management of selected difficult-to-treat Gram-negative bacterial infections. Its importance is closely connected with the growing challenge of antibiotic resistance and the complex beta-lactamase mechanisms found in some resistant bacteria. Meblanios contains Aztreonam 1500 mg and Avibactam 500 mg. The two components have different roles:...
Read More